Search Results - "Chandu, Ala"

Refine Results
  1. 1

    Filamin A Regulates Cardiovascular Remodeling by Bandaru, Sashidar, Ala, Chandu, Zhou, Alex-Xianghua, Akyürek, Levent M.

    “…Filamin A (FLNA) is a large actin-binding cytoskeletal protein that is important for cell motility by stabilizing actin networks and integrating them with cell…”
    Get full text
    Journal Article
  2. 2

    A critical review of therapeutic interventions in sickle cell disease: Progress and challenges by Ala, Chandu, Joshi, Renuka Parshuram, Gupta, Pragya, Goswami, Sangam Giri, Ramalingam, Sivaprakash, Kondapalli Venkata Gowri, Chandra Sekhar, Sankaranarayanan, Murugesan

    Published in Archiv der Pharmazie (Weinheim) (01-11-2024)
    “…Sickle cell disease (SCD) is an autosomal recessive genetic disorder that occurs due to the point mutation in the β‐globin gene, which results in the formation…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The MTH1 inhibitor TH588 is a microtubule-modulating agent that eliminates cancer cells by activating the mitotic surveillance pathway by Gul, Nadia, Karlsson, Joakim, Tängemo, Carolina, Linsefors, Sanna, Tuyizere, Samuel, Perkins, Rosie, Ala, Chandu, Zou, Zhiyuan, Larsson, Erik, Bergö, Martin O., Lindahl, Per

    Published in Scientific reports (11-10-2019)
    “…The mut-T homolog-1 (MTH1) inhibitor TH588 has shown promise in preclinical cancer studies but its targeting specificity has been questioned. Alternative…”
    Get full text
    Journal Article
  5. 5

    Lack of RAC1 in macrophages protects against atherosclerosis by Bandaru, Sashidar, Ala, Chandu, Ekstrand, Matias, Akula, Murali K, Pedrelli, Matteo, Liu, Xi, Bergström, Göran, Håversen, Liliana, Borén, Jan, Bergo, Martin O, Akyürek, Levent M, Lutgens, Esther, Bader, Michael

    Published in PloS one (17-09-2020)
    “…The Rho GTPase RAC1 is an important regulator of cytoskeletal dynamics, but the role of macrophage-specific RAC1 has not been explored during atherogenesis. We…”
    Get full text
    Journal Article
  6. 6

    Development and Biological Evaluation of Novel Spiro 4‐Chromanones as Potent Quorum Sensing Inhibitors by Sai Chaitanya, Kosana, Gupta, Pooja, Chitti, Surendar, Khetmalis, Yogesh Mahadu, Chandu, Ala, Murugesan, Sankaranarayanan, Pasupuleti, Mukesh

    Published in Journal of chemistry (31-08-2024)
    “…Infectious diseases are an integral part of human life and have the potential to cause significant damage to life. Currently, antimicrobial agents are no…”
    Get full text
    Journal Article
  7. 7

    Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approaches by Ala, Chandu, Joshi, Renuka Parshuram, Gupta, Pragya, Ramalingam, Sivaprakash, Sankaranarayanan, Murugesan

    “…Sickle cell disease (SCD) is an autosomal recessive genetic disorder affecting millions of people worldwide. A reversible and selective DNMT1 inhibitor,…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents by Nakka, Srinuvasu, Raza, Asif, Chaitanya, Kosana Sai, Bandaru, Naga Venkata Madhusudhan Rao, Chandu, Ala, Murugesan, Sankaranarayanan, Devunuri, Nagaraju, Sharma, Arun K., Chandrasekhar, Kondapalli Venkata Gowri

    Published in Chemical biology & drug design (01-03-2024)
    “…We designed and synthesized thirty novel quinoxaline aryl ethers as anticancer agents, and the structures of final compounds were confirmed with various…”
    Get full text
    Journal Article
  14. 14

    Design, synthesis, and anti-mycobacterial evaluation of 1,8-naphthyridine-3-carbonitrile analogues by Khetmalis, Yogesh Mahadu, Shobha, Singarapalle, Nandikolla, Adinarayana, Chandu, Ala, Murugesan, Sankaranarayanan, Kumar, Muthyala Murali Krishna, Chandra Sekhar, Kondapalli Venkata Gowri

    Published in RSC advances (12-07-2024)
    “…Twenty-eight compounds, , 1,8-naphthyridine-3-carbonitrile (ANC and ANA) derivatives, were designed and synthesized through a molecular hybridization approach…”
    Get full text
    Journal Article
  15. 15

    Targeting Filamin A Reduces Macrophage Activity and Atherosclerosis by Bandaru, Sashidar, Ala, Chandu, Salimi, Reza, Akula, Murali K, Ekstrand, Matias, Devarakonda, Sravani, Karlsson, Joakim, Van den Eynden, Jimmy, Bergström, Göran, Larsson, Erik, Levin, Max, Borén, Jan, Bergo, Martin O, Akyürek, Levent M

    Published in Circulation (New York, N.Y.) (02-07-2019)
    “…BACKGROUND:The actin-binding protein FLNA (filamin A) regulates signal transduction important for cell locomotion, but the role of macrophage-specific FLNA…”
    Get full text
    Journal Article
  16. 16

    Unlocking nitrogen compounds’ promise against malaria: A comprehensive review by Kuthe, Pranali Vijaykumar, Muzaffar‐Ur‐Rehman, Mohammad, Chandu, Ala, Prashant, Kirad Shivani, Sankarnarayanan, Murugesan

    Published in Archiv der Pharmazie (Weinheim) (01-09-2024)
    “…Plasmodium parasites are the primary cause of malaria, leading to high mortality rates, which require clinical attention. Many of the medications used in the…”
    Get full text
    Journal Article
  17. 17

    Blocking the Cleavage of Filamin A by Calpain Inhibitor Decreases Tumor Cell Growth by Salimi, Reza, Bandaru, Sashidhar, Devarakonda, Sravani, Gökalp, Sevtap, Ala, Chandu, Alvandian, Ali, Yener, Nilgün, Akyürek, Levent M

    Published in Anticancer research (01-04-2018)
    “…Filamin A (FLNA) is the most abundant and widely expressed isoform of filamin in human tissues. It is cleaved by calpain at the hinge 1 and 2 domains,…”
    Get full text
    Journal Article
  18. 18

    In Silico Exploration of Bisphosphonate Scaffolds as Potential Inhibitors of SARS-CoV-2 RdRp for COVID-19 and PASC by Mohammed, Muzaffar-Ur-Rehman, Chougule, Suryakant, Ala, Chandu, Kuthe, Pranali Vijaykumar, Garg, Mohit, Sankaranarayanan, Murugesan, Vasan, Seshadri S

    Published in Pathogens (Basel) (2023)
    “…The novel coronavirus disease (COVID-19) pandemic has resulted in over 720 million confirmed cases and 7 million deaths worldwide, with insufficient treatment…”
    Get full text
    Journal Article
  19. 19

    Design, synthesis and biological evaluation of novel oxindole analogs as antitubercular agents by Khetmalis, Yogesh M, Sangeetha, Guruvelli PV, Chandu, Ala, Swati, Murugesan, Sankaranarayanan, Sharma, Vivek, Kumar, Muthyala MK, Kondapalli, Venkata GCS

    Published in Future medicinal chemistry (01-08-2023)
    “…To design, synthesize and evaluate oxindole derivatives for antitubercular activity. We synthesized the derivatives, confirmed their structures by H/ C NMR and…”
    Get full text
    Journal Article
  20. 20

    Targeting filamin A reduces macrophage activity and atherosclerosis: Filamin A in atherogenesis by Bandaru, Sashidar, Ala, Chandu, Salimi, Reza, Akula, Murali K, Ekstrand, Matias, Devarakonda, Sravani, Karlsson, Joakim, Van den Eynden, Jimmy, Bergström, Göran, Levin, Max, Borén, Jan, Bergö, Martin O., Akyürek, Levent

    Published in Circulation (New York, N.Y.) (2019)
    “…The actin-binding protein FLNA (filamin A) regulates signal transduction important for cell locomotion, but the role of macrophage-specific FLNA during…”
    Get full text
    Journal Article